386 related articles for article (PubMed ID: 26720458)
1. Oral Lutein Supplementation Enhances Macular Pigment Density and Contrast Sensitivity but Not in Combination With Polyunsaturated Fatty Acids.
Wolf-Schnurrbusch UE; Zinkernagel MS; Munk MR; Ebneter A; Wolf S
Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8069-74. PubMed ID: 26720458
[TBL] [Abstract][Full Text] [Related]
2. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.
Ma L; Yan SF; Huang YM; Lu XR; Qian F; Pang HL; Xu XR; Zou ZY; Dong PC; Xiao X; Wang X; Sun TT; Dou HL; Lin XM
Ophthalmology; 2012 Nov; 119(11):2290-7. PubMed ID: 22858124
[TBL] [Abstract][Full Text] [Related]
3. Effect of Dietary Supplementation With Lutein, Zeaxanthin, and ω-3 on Macular Pigment: A Randomized Clinical Trial.
Korobelnik JF; Rougier MB; Delyfer MN; Bron A; Merle BMJ; Savel H; Chêne G; Delcourt C; Creuzot-Garcher C
JAMA Ophthalmol; 2017 Nov; 135(11):1259-1266. PubMed ID: 28973076
[TBL] [Abstract][Full Text] [Related]
4. Effect of supplemental lutein and zeaxanthin on serum, macular pigmentation, and visual performance in patients with early age-related macular degeneration.
Huang YM; Dou HL; Huang FF; Xu XR; Zou ZY; Lin XM
Biomed Res Int; 2015; 2015():564738. PubMed ID: 25815324
[TBL] [Abstract][Full Text] [Related]
5. Macular xanthophylls and ω-3 long-chain polyunsaturated fatty acids in age-related macular degeneration: a randomized trial.
Arnold C; Winter L; Fröhlich K; Jentsch S; Dawczynski J; Jahreis G; Böhm V
JAMA Ophthalmol; 2013 May; 131(5):564-72. PubMed ID: 23519529
[TBL] [Abstract][Full Text] [Related]
6. Macular pigment density variation after supplementation of lutein and zeaxanthin using the Visucam
Azar G; Quaranta-El Maftouhi M; Masella JJ; Mauget-Faÿsse M
J Fr Ophtalmol; 2017 Apr; 40(4):303-313. PubMed ID: 28336284
[TBL] [Abstract][Full Text] [Related]
7. Changes in Macular Pigment Optical Density and Serum Lutein Concentration in Japanese Subjects Taking Two Different Lutein Supplements.
Obana A; Tanito M; Gohto Y; Okazaki S; Gellermann W; Bernstein PS
PLoS One; 2015; 10(10):e0139257. PubMed ID: 26451726
[TBL] [Abstract][Full Text] [Related]
8. Supplementation with three different macular carotenoid formulations in patients with early age-related macular degeneration.
Sabour-Pickett S; Beatty S; Connolly E; Loughman J; Stack J; Howard A; Klein R; Klein BE; Meuer SM; Myers CE; Akuffo KO; Nolan JM
Retina; 2014 Sep; 34(9):1757-66. PubMed ID: 24887490
[TBL] [Abstract][Full Text] [Related]
9. Changes following supplementation with lutein and zeaxanthin in retinal function in eyes with early age-related macular degeneration: a randomised, double-blind, placebo-controlled trial.
Huang YM; Dou HL; Huang FF; Xu XR; Zou ZY; Lu XR; Lin XM
Br J Ophthalmol; 2015 Mar; 99(3):371-5. PubMed ID: 25228440
[TBL] [Abstract][Full Text] [Related]
10. Serum and retinal responses to three different doses of macular carotenoids over 12 weeks of supplementation.
Stringham JM; Stringham NT
Exp Eye Res; 2016 Oct; 151():1-8. PubMed ID: 27426932
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on photostress recovery, glare disability, and chromatic contrast.
Hammond BR; Fletcher LM; Roos F; Wittwer J; Schalch W
Invest Ophthalmol Vis Sci; 2014 Dec; 55(12):8583-9. PubMed ID: 25468896
[TBL] [Abstract][Full Text] [Related]
12. Plasma long-chain omega-3 polyunsaturated fatty acids and macular pigment in subjects with family history of age-related macular degeneration: the Limpia Study.
Merle BMJ; Buaud B; Korobelnik JF; Bron A; Delyfer MN; Rougier MB; Savel H; Vaysse C; Creuzot-Garcher C; Delcourt C
Acta Ophthalmol; 2017 Dec; 95(8):e763-e769. PubMed ID: 28271618
[TBL] [Abstract][Full Text] [Related]
13. LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls.
Richer S; Devenport J; Lang JC
Optometry; 2007 May; 78(5):213-9. PubMed ID: 17478338
[TBL] [Abstract][Full Text] [Related]
14. Pilot evaluation of short-term changes in macular pigment and retinal sensitivity in different phenotypes of early age-related macular degeneration after carotenoid supplementation.
Corvi F; Souied EH; Falfoul Y; Georges A; Jung C; Querques L; Querques G
Br J Ophthalmol; 2017 Jun; 101(6):770-773. PubMed ID: 27587715
[TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973.
Richer SP; Stiles W; Graham-Hoffman K; Levin M; Ruskin D; Wrobel J; Park DW; Thomas C
Optometry; 2011 Nov; 82(11):667-680.e6. PubMed ID: 22027699
[TBL] [Abstract][Full Text] [Related]
16. Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study.
Dawczynski J; Jentsch S; Schweitzer D; Hammer M; Lang GE; Strobel J
Graefes Arch Clin Exp Ophthalmol; 2013 Dec; 251(12):2711-23. PubMed ID: 23695657
[TBL] [Abstract][Full Text] [Related]
17. Enrichment of Macular Pigment Enhances Contrast Sensitivity in Subjects Free of Retinal Disease: Central Retinal Enrichment Supplementation Trials - Report 1.
Nolan JM; Power R; Stringham J; Dennison J; Stack J; Kelly D; Moran R; Akuffo KO; Corcoran L; Beatty S
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3429-39. PubMed ID: 27367585
[TBL] [Abstract][Full Text] [Related]
18. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study.
Trieschmann M; Beatty S; Nolan JM; Hense HW; Heimes B; Austermann U; Fobker M; Pauleikhoff D
Exp Eye Res; 2007 Apr; 84(4):718-28. PubMed ID: 17306793
[TBL] [Abstract][Full Text] [Related]
19. Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
; Bonds DE; Harrington M; Worrall BB; Bertoni AG; Eaton CB; Hsia J; Robinson J; Clemons TE; Fine LJ; Chew EY
JAMA Intern Med; 2014 May; 174(5):763-71. PubMed ID: 24638908
[TBL] [Abstract][Full Text] [Related]
20. [The macular pigment: short- and intermediate-term changes of macular pigment optical density following supplementation with lutein and zeaxanthin and co-antioxidants. The LUNA Study].
Zeimer M; Hense HW; Heimes B; Austermann U; Fobker M; Pauleikhoff D
Ophthalmologe; 2009 Jan; 106(1):29-36. PubMed ID: 18551295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
